JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crowther, R.
Right arrow Articles by Rangachari, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crowther, R.
Right arrow Articles by Rangachari, P. K.

Functional subtyping of neurokinin receptors on canine proximal colonic mucosa

R Crowther, D Jukic, D Regoli and PK Rangachari

Honours Biology-Pharmacology Programme, McMaster University, Hamilton, Ontario, Canada.

Functional subtyping of the receptors responsible for the neural and nonneural effects of substance P (SP) on the canine proximal colon were studied. Selective agonists and antagonists were used with two different in vitro preparations. The mucosa contained the muscularis mucosa and attendant submucosal plexuses, whereas the epithelium was devoid of both. We obtained the following results: [Sar9,Met(O2)11]SP (Sar9SP), a neurokinin-1 receptor agonist, stimulated both preparations; senktide, a neurokinin-3 agonist, evoked a response only on the mucosal preparation; [beta-Ala8]NKA4-10, a neurokinin-2 agonist, was ineffective on both preparations; tetrodotoxin completely inhibited the mucosal responses to senktide, but the inhibitory effects on Sar9SP were only partial; CP-96,345, a neurokinin-1-selective antagonist, inhibited both epithelial and mucosal responses to Sar9SP and R487 [Trp7,beta-Ala8]NKA4-10, a neurokinin-3 antagonist, inhibited mucosal responses to senktide. Thus, the neural effects involved both neurokinin-1 and neurokinin-3 receptors, whereas the nonneural effects were mediated by neurokinin-1 receptors alone. Neurokinin-2 receptors were functionally absent.

Volume 268, Issue 3, pp. 1374-1380, 03/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
D. Renzi, B. Pellegrini, F. Tonelli, C. Surrenti, and A. Calabro
Substance P (Neurokinin-1) and Neurokinin A (Neurokinin-2) Receptor Gene and Protein Expression in the Healthy and Inflamed Human Intestine
Am. J. Pathol., November 1, 2000; 157(5): 1511 - 1522.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics.